Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.
Highest usefulness score first. Studies without a score come last.
-
The elastic net model that included age, age x sex interaction, allelic APOE terms, and 29 additional SNPs performed the best.
-
59/100
The PRS for AD was significantly higher in APOE ε4 homozygote AD cases compared to older cognitively healthy APOE ε4/ε4 controls (odds ratio [OR] 8.39; confidence interval [CI] 2.0-35.2; P = .003).
-
59/100
Sporadic Alzheimer's disease (AD) exclusively affects elderly people.
-
Diabetes was associated with shorter lifespan in APOE3 carriers (n = 12,415, HR = 1.29, 95%CI = 1.17-1.42, p < 0.001) and APOE2 carriers (n = 2,390, HR = 1.37, 95%CI = 1.10-1.69, p = 0.016), while such associations were weaker and not significant in APOE4 carriers (n = 9,490, HR = 1.11, 95%CI = 0.99-1.24, p = 0.162).
-
The novel respiratory disease COVID-19 produces varying symptoms, with fever, cough, and shortness of breath being common.
-
Widespread DMN FC changes were shown in frontal and posterior areas, as well as in the right hippocampus.
-
Tau and amyloid beta (Aβ) proteins accumulate along neuronal circuits in Alzheimer's disease.
-
A variant in AKAP9, p.R434W, segregated significantly with LOAD in two large families (OR = 5.77, 95% CI: 1.07-30.9, P = 0.041).
-
Growing evidence indicates that apolipoprotein E (ApoE) is one of the most important candidate genes for influencing the development of hemodialysis (HD).
-
Apolipoprotein E (apoE) is a polymorphic gene involved in lipid metabolism with three common variant alleles (epsilon2, epsilon3, and epsilon4).
-
Subjective cognitive decline (SCD) is widely regarded as a potential preclinical stage of Alzheimer's disease (AD), yet its genetic basis remains poorly understood.
-
ApoE4 levels ascertained by the e4Quant test exhibited clear genotype-dependent stratification.
-
Genome-wide association studies (GWAS) have identified >80 Alzheimer's disease and related dementias (ADRD)-associated genetic loci.
-
Alzheimer's disease (AD) is the most common form of dementia and a growing public health burden in the United States.
-
We retrospectively assessed the diagnostic accuracy of whole genome sequencing to detect the most common repeat expansion loci associated with neurological outcomes (AR, ATN1, ATXN1, ATXN2, ATXN3, ATXN7, C9orf72, CACNA1A, DMPK, FMR1, FXN, HTT, and TBP) using samples obtained within the National Health Service in England from patients who were suspected of having neurological disorders; previous PCR test results were used as the reference standard.
-
UK Biobank is a major prospective epidemiological study, including multimodal brain imaging, genetics and ongoing health outcomes.
-
Although abnormal accumulation of amyloid in the brain is an early biomarker of Alzheimer's disease (AD), wide variation in cognitive trajectories during life can be seen in the setting of brain amyloidosis, ranging from maintenance of normal function to progression to dementia.
-
57/100
Deriving disease subtypes from electronic health records (EHRs) can guide next-generation personalized medicine.
-
Methylation across all the CpGs strongly correlated with each other.
-
We identified associations in EAs with variants in 12 novel loci.
-
Alzheimer's disease (AD) affects half the US population over the age of 85 and is universally fatal following an average course of 10 years of progressive cognitive disability.
-
Arousal affects cognition, emotion, and behavior and has been implicated in the etiology of psychiatric disorders.
-
Higher GRS predicted mortality (hazard ratio = 1.05; 95% confidence interval: 1.00-1.10, P = .04).
-
People's differences in cognitive functions are partly heritable and are associated with important life outcomes.
-
Inherited lifetime exposure to higher SBP is associated with lower AD risk.
From across this topic
9 of the 933 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- APOE2: protective mechanism and therapeutic implications for Alzheimer's disease
- Spatial proximity to AD pathology defines cell-type and genotype-specific characteristics in human AD hippocampus
- hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data
- Shared genes and pathways in dementia: Insights from genome-wide association studies
- Early-onset familial Alzheimer's disease in a family with mutation of presenilin 2 gene
- SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis
- APOE genotype-dependent differences in human astrocytic energy metabolism
- Apolipoprotein E and Alzheimer's Disease: Findings, Hypotheses, and Potential Mechanisms
- APOE -ε4 allele[s]-associated adverse events reported from placebo arm in clinical trials for Alzheimer's disease: implications for anti-amyloid beta therapy